Function of ACAP4 in CCL18-stimulated breast cancer metastasis

ACAP4 在 CCL18 刺激的乳腺癌转移中的功能

基本信息

  • 批准号:
    8373302
  • 负责人:
  • 金额:
    $ 29.36万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-09-01 至 2017-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Metastasis, cancer spreading, is often a final and fatal stage in the progression of solid malignancies. Early detection of localized breast cancer results in a higher relative five-year survival rate (98%) while the relative five-year survival rae drops significantly (26%) for those women who have distant metastases. Therefore, a better understanding of mechanistic insight regarding the development and progression of this disease is of extreme importance in clinical setting. Our study revealed that cytokine CCL18 released from tumor-associated macrophage promotes breast cancer metastasis and serves as a novel indicator for poor survival in the clinical oncology (Chen et al., 2011. Cancer Cell). In addition, our recent study identified a breast cancer metastasis signaling network involving CCL18 and its potential effectors ARF6-ACAP4-ezrin. However, little is known regarding the molecular mechanism(s) by which CCL18 operates in breast cancer metastasis. The long-term goal of our research is to delineate how ARF6-ACAP4-ezrin interaction orchestrates stimulus-coupled breast cancer metastasis. To address this question, three Specific Aims are proposed: first, we will delineate the ARF6 activity gradient underlying breast cancer cell dynamics using a novel biosensor combined with ACAP4 small molecule inhibitors; second, we evaluate how phospho-ezrin interacts with ACAP4 using epitope-tagging, chemical foot-printing, and cross-linking approaches. These studies will involve a detailed analysis of the structural determinants that mediate a direct ezrin-ACAP4 contact. Binding domain data will be used to design peptides that potently and specifically perturb ezrin-ACAP4 interactions in in vitro binding assays. The importance of such an interaction in breast cancer invasion will then be evaluated by functional assay and supra-resolution imaging analysis. Third, we plan to investigate the potential mechanisms underlying ACAP4-mediated breast cancer interacts in animals. These studies will be facilitated by in vivo bioluminescence images coupled with small molecule inhibitor treatment in live xenografted animals. Studying the molecular mechanisms underlying breast cancer metastasis is of great significance in understanding the solid tumor progression, and is also expected to be of great benefit in leading to pharmacological strategies for preventing tumor cell spreading. PUBLIC HEALTH RELEVANCE: The proposed line of investigations represents a highly integrated translational effort to delineate breast tumor metastasis and provide a strategy for disease intervention.
描述(由申请人提供):转移,癌症扩散,通常是实体恶性肿瘤进展的最终和致命阶段。局部乳腺癌的早期发现导致较高的相对五年生存率(98%),而对于那些有远处转移的妇女,相对五年生存率显著下降(26%)。因此,更好地了解关于这种疾病的发展和进展的机制见解在临床环境中是极其重要的。我们的研究揭示,从肿瘤相关巨噬细胞释放的细胞因子CCL 18促进乳腺癌转移,并在临床肿瘤学中充当存活率差的新指标(Chen et al.,2011. Cancer Cell)。此外,本发明还提供了一种方法, 我们最近的研究鉴定了涉及CCL 18及其潜在效应物ARF 6-ACAP 4-ezrin的乳腺癌转移信号传导网络。然而,关于CCL 18在乳腺癌转移中起作用的分子机制知之甚少。我们研究的长期目标是描述ARF 6-ACAP 4-ezrin相互作用如何协调刺激偶联的乳腺癌转移。为了解决这个问题,提出了三个具体的目标:首先,我们将描绘的ARF 6活性梯度乳腺癌细胞动力学使用一种新的生物传感器结合ACAP 4小分子抑制剂;其次,我们评估磷酸埃兹蛋白如何与ACAP 4使用表位标签,化学足迹,和交联方法相互作用。这些研究将涉及介导直接ezrin-ACAP 4接触的结构决定因素的详细分析。结合结构域数据将用于设计在体外结合测定中有效且特异性地干扰ezrin-ACAP 4相互作用的肽。这种相互作用在乳腺癌侵袭中的重要性将通过功能测定和超分辨率成像分析来评估。第三,我们计划在动物中研究ACAP 4介导的乳腺癌相互作用的潜在机制。这些研究将通过在活体异种移植动物中结合小分子抑制剂治疗的体内生物发光图像来促进。 研究乳腺癌转移的分子机制对于了解实体瘤的进展具有重要意义,并且预计也将对预防肿瘤细胞扩散的药理学策略产生巨大益处。 公共卫生相关性:提出的调查线代表了一个高度集成的翻译努力,描绘乳腺肿瘤转移,并提供了一个战略,疾病干预。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

XUEBIAO YAO其他文献

XUEBIAO YAO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('XUEBIAO YAO', 18)}}的其他基金

FUNCTION OF MST4-EZRIN-ACAP4 SIGNALING IN GASTRIC PARIETAL CELL SECRETION AND HOMEOSTASIS
MST4-EZRIN-ACAP4 信号传导在胃壁细胞分泌和稳态中的功能
  • 批准号:
    9753750
  • 财政年份:
    2017
  • 资助金额:
    $ 29.36万
  • 项目类别:
Function of ACAP4 in CCL18-stimulated breast cancer metastasis
ACAP4 在 CCL18 刺激的乳腺癌转移中的功能
  • 批准号:
    8681389
  • 财政年份:
    2012
  • 资助金额:
    $ 29.36万
  • 项目类别:
Function of ACAP4 in CCL18-stimulated breast cancer metastasis
ACAP4 在 CCL18 刺激的乳腺癌转移中的功能
  • 批准号:
    8538904
  • 财政年份:
    2012
  • 资助金额:
    $ 29.36万
  • 项目类别:
Function of ACAP4 in CCL18-stimulated breast cancer metastasis
ACAP4 在 CCL18 刺激的乳腺癌转移中的功能
  • 批准号:
    8876604
  • 财政年份:
    2012
  • 资助金额:
    $ 29.36万
  • 项目类别:
EZRIN IN STIMULUS-COUPLED GASTRIC ACID SECRETION
Ezrin 在刺激耦合胃酸分泌中的作用
  • 批准号:
    6446861
  • 财政年份:
    1999
  • 资助金额:
    $ 29.36万
  • 项目类别:
EZRIN IN STIMULUS-COUPLED GASTRIC ACID SECRETION
Ezrin 在刺激耦合胃酸分泌中的作用
  • 批准号:
    6742921
  • 财政年份:
    1999
  • 资助金额:
    $ 29.36万
  • 项目类别:
EZRIN IN STIMULUS-COUPLED GASTRIC ACID SECRETION
Ezrin 在刺激耦合胃酸分泌中的作用
  • 批准号:
    2898639
  • 财政年份:
    1999
  • 资助金额:
    $ 29.36万
  • 项目类别:
The function of ezrin in stimulus-coupled acid secretion
埃兹蛋白在刺激耦合酸分泌中的功能
  • 批准号:
    7027717
  • 财政年份:
    1999
  • 资助金额:
    $ 29.36万
  • 项目类别:
The function of ezrin in stimulus-coupled acid secretion
埃兹蛋白在刺激耦合酸分泌中的功能
  • 批准号:
    7171887
  • 财政年份:
    1999
  • 资助金额:
    $ 29.36万
  • 项目类别:
EZRIN IN STIMULUS-COUPLED GASTRIC ACID SECRETION
Ezrin 在刺激耦合胃酸分泌中的作用
  • 批准号:
    6177948
  • 财政年份:
    1999
  • 资助金额:
    $ 29.36万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 29.36万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 29.36万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.36万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.36万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 29.36万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.36万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 29.36万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 29.36万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 29.36万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.36万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了